19 research outputs found
TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis
This work was funded by UCLH NIHR BRC (sample collection), Wellcome Trust Investigator award (MKM) and
Clinical Research Training Fellowship (USG); Medical Research Council grant (MKM) and Clinician Scientist
Fellowship (DP); EASL fellowship (IO); National Health and Medical Research Council Australia (KPS)
Therapeutic potential of TLR8 agonist GS-9688 (selgantolimod) in chronic hepatitis B: re-modelling of antiviral and regulatory mediators
Background & Aims:
GSā9688 (selgantolimod) is a tollālike receptor 8 (TLR8) agonist in clinical development for the treatment of chronic hepatitis B (CHB). Antiviral activity of GSā9688 has previously been evaluated in vitro in hepatitis B virus (HBV)āinfected hepatocytes and in vivo in the woodchuck model of CHB. Here we evaluated the potential of GSā9688 to boost responses contributing to viral control and to modulate regulatory mediators.
Approach & Results:
We characterised the effect of GSā9688 on immune cell subsets in vitro in PBMC of healthy controls and CHB patients. GSā9688 activated dendritic cells and mononuclear phagocytes to produce ILā12 and other immunomodulatory mediators, inducing a comparable cytokine profile in healthy controls and CHB patients. GSā9688 increased the frequency of activated natural killer (NK) cells, mucosalāassociated invariant Tācells (MAITs), CD4+ follicular helper Tācells (TFH) and, in ~50% of patients, HBVāspecific CD8+Tācells expressing interferonāĪ³ (IFNĪ³). Moreover, in vitro stimulation with GSā9688 induced NK cell expression of IFNĪ³ and TNFĪ± and promoted hepatocyte lysis. We also assessed whether GSā9688 inhibited immunosuppressive cell subsets that might enhance antiviral efficacy. Stimulation with GSā9688 reduced the frequency of CD4+ regulatory Tācells and monocytic myeloidāderived suppressor cells (MDSC). Residual MDSC expressed higher levels of negative immune regulators, galectinā9 and PDāL1. Conversely, GSā9688 induced an expansion of immunoregulatory TNFārelated apoptosisāinducing ligand+ (TRAIL) regulatory NK cells and degranulation of arginaseāI+ polymorphonuclearāMDSC (PMNāMDSC).
Conclusions:
GSā9688 induces cytokines in human PBMC that are able to activate antiviral effector function by multiple immune mediators (HBVāspecific CD8+Tācells, TFH, NK cells and MAITs). Whilst reducing the frequency of some immunoregulatory subsets, it enhances the immunosuppressive potential of others, highlighting potential biomarkers and immunotherapeutic targets to optimise the antiviral efficacy of GSā9688
Description and evaluation of an EBM curriculum using a block rotation
BACKGROUND: While previous authors have emphasized the importance of integrating and reinforcing evidence-based medicine (EBM) skills in residency, there are few published examples of such curricula. We designed an EBM curriculum to train family practice interns in essential EBM skills for information mastery using clinical questions generated by the family practice inpatient service. We sought to evaluate the impact of this curriculum on interns, residents, and faculty. METHODS: Interns (n = 13) were asked to self-assess their level of confidence in basic EBM skills before and after their 2-week EBM rotation. Residents (n = 21) and faculty (n = 12) were asked to assess how often the answers provided by the EBM intern to the inpatient service changed medical care. In addition, residents were asked to report how often they used their EBM skills and how often EBM concepts and tools were used in teaching by senior residents and faculty. Faculty were asked if the EBM curriculum had increased their use of EBM in practice and in teaching. RESULTS: Interns significantly increased their confidence over the course of the rotation. Residents and faculty felt that the answers provided by the EBM intern provided useful information and led to changes in patient care. Faculty reported incorporating EBM into their teaching (92%) and practice (75%). Residents reported applying the EBM skills they learned to patient care (86%) and that these skills were reinforced in the teaching they received outside of the rotation (81%). All residents and 11 of 12 faculty felt that the EBM curriculum had improved patient care. CONCLUSIONS: To our knowledge, this is the first published EBM curriculum using an individual block rotation format. As such, it may provide an alternative model for teaching and incorporating EBM into a residency program
Use of RNAlater in fluorescence-activated cell sorting (FACS) reduces the fluorescence from GFP but not from DsRed
<p>Abstract</p> <p>Background</p> <p>Flow cytometry utilizes signals from fluorescent markers to separate targeted cell populations for gene expression studies. However, the stress of the FACS process could change normal gene expression profiles. RNAlater could be used to stop such changes in original gene expression profiles through its ability to denature RNase and other proteins. The normal conformational structure of fluorescent proteins must be maintained in order to fluoresce. Whether or not RNAlater would affect signals from different types of intrinsic fluorescent proteins is crucial to its use in flow cytometry; this question has not been investigated in detail.</p> <p>Findings</p> <p>To address this question, we analyzed the effect of RNAlater on fluorescence intensity of GFP, YFP, DsRed and small fluorescent molecules attached to secondary antibodies (Cy2 and Texas-Red) when used in flow cytometry. FACS results were confirmed with fluorescence microscopy. Our results showed that exposure of YFP and GFP containing cells to RNAlater reduces the intensity of their fluorescence to such an extent that separation of such labeled cells is difficult if not impossible. In contrast, signals from DsRed2, Cy2 and Texas-Red were not affected by RNAlater treatment. In addition, the background fluorescence and clumping of dissociated cells are altered by RNAlater treatment.</p> <p>Conclusions</p> <p>When considering gene expression studies using cell sorting with RNAlater, DsRed is the fluorescent protein of choice while GFP/YFP have severe limitations because of their reduced fluorescence. It is necessary to examine the effects of RNAlater on signals from fluorescent markers and the physical properties (e.g., clumping) of the cells before considering its use in cell sorting.</p
Expression of CD3-Ī¶ on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes
Lymphocytic infiltrate is often present in cervical cancer lesions, possibly reflecting an ongoing, but ineffective, immune response to the tumour. Recently, evidence has accumulated for systemically impaired T-cell functions in cancer patients, associated with decreased expression of signal-transducing zeta (Ī¶) chain dimer molecules on circulating T-cells and NK-cells. Here, we report on the intralesional down-regulation of Ī¶ chain expression on T-cells in cervical carcinoma. Paraffin-embedded or snap-frozen sections from 24 different cervical cancer specimens were studied. Paraffin-embedded tumour-positive (n = 7) and tumour-negative (n = 15) pelvic lymph nodes were also included in the study. Immunostaining was performed on consecutive sections with antibodies specific for CD3-É or the CD3-associated Ī¶ chain dimer. Antigen retrieval by sodium citrate/microwave treatment was essential for Ī¶ staining of paraffin sections. The amount of Ī¶ positive cells was quantitated and related to the number of CD3-É+ cells in corresponding tumour areas. Of the 24 cervical cancer specimens studied, Ī¶ chain dimer expression was reduced in seven cases and strongly reduced in the other 17 samples. In tonsil control sections, CD3-É and CD3-Ī¶ were always co-expressed in almost equal numbers. Also, both tumour-negative and -positive lymph nodes showed Ī¶ chain expression which equalled that of CD3-É expression. These data indicate that a decreased expression of signal-transducing Ī¶ molecules on tumour-infiltrating T-cells is frequent in cervical cancer. The apparently unimpaired Ī¶ chain expression within draining lymph nodes suggests that local tumour-derived factors at the primary site are instrumental in Ī¶ chain down-regulation. Ā© 1999 Cancer Research Campaig
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease
BACKGROUND: Liver biopsy is considered as the gold standard for assessing non-alcoholic fatty liver disease (NAFLD) histologic lesions. The aim of this study was to determine the diagnostic utility of non-invasive markers of fibrosis, validated in chronic viral hepatitis and alcoholic liver disease (FibroTest, FT), in patients with NAFLD. METHODS: 170 patients with suspected NAFLD were prospectively included in a reference center (Group 1), 97 in a multicenter study (Group 2) and 954 blood donors as controls. Fibrosis was assessed on a 5 stage histological scale validated by Kleiner et al from F0 = none, F1 = perisinusoidal or periportal, F2 = perisinusoidal and portal/periportal, F3 = bridging and F4 = cirrhosis. Histology and the biochemical measurements were blinded to any other characteristics. The area under the ROC curves (AUROC), sensitivity (Se), specificity (Sp), positive and negative predictive values (PPV, NPV) were assessed. RESULTS: In both groups FT has elevated and not different AUROCs for the diagnosis of advanced fibrosis (F2F3F4): 0.86 (95%CI 0.77ā0.91) versus 0.75 (95%CI 0.61ā0.83; P = 0.10), and for F3F4: 0.92 (95%CI 0.83ā0.96) versus 0.81 (95%CI 0.64ā0.91; P = 0.12) in Group1 and Group 2 respectively. When the 2 groups were pooled together a FT cutoff of 0.30 had a 90% NPV for advanced fibrosis (Se 77%); a FT cutoff of 0.70 had a 73% PPV for advanced fibrosis (Sp 98%). CONCLUSION: In patients with NAFLD, FibroTest, a simple and non-invasive quantitative estimate of liver fibrosis reliably predicts advanced fibrosis